CN110272921A - A kind of safe and efficient CRISPR/Cas9 gene editing method - Google Patents

A kind of safe and efficient CRISPR/Cas9 gene editing method Download PDF

Info

Publication number
CN110272921A
CN110272921A CN201910536641.1A CN201910536641A CN110272921A CN 110272921 A CN110272921 A CN 110272921A CN 201910536641 A CN201910536641 A CN 201910536641A CN 110272921 A CN110272921 A CN 110272921A
Authority
CN
China
Prior art keywords
added
dna
solution
cas9
safe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910536641.1A
Other languages
Chinese (zh)
Inventor
杨国华
王磊
李季
胡俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Hundred Wing Biological Technology Co Ltd
Original Assignee
Wuhan Hundred Wing Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Hundred Wing Biological Technology Co Ltd filed Critical Wuhan Hundred Wing Biological Technology Co Ltd
Priority to CN201910536641.1A priority Critical patent/CN110272921A/en
Publication of CN110272921A publication Critical patent/CN110272921A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses

Abstract

The present invention relates to gene engineering technology fields, especially a kind of safe and efficient CRISPR/Cas9 gene editing method, the following steps are included: S1, being determined to the target-gene sequence on target gene, and open the DNA double spiral of target gene, using Cas9 vitro enzyme to it into shearing, the DNA sequence dna of target gene causes to be broken, and knockout goes genetic fragment in spite of illness;S2, sgRNA sequence is designed, and carried out artificial synthesized;S3, the bacterium for choosing competence, thaw to it;S4, strain is inoculated into BL solution, keeping temperature is 37 DEG C, is cultivated in the environment that revolving speed is 250r/min, and stayed overnight;S5, picking monoclonal, using alkaline lysis method of extracting plasmid;The DMEM culture medium of S6, absorption serum-free and antibiotic are added 6 μ l transfection reagent PEI and piping and druming are uniformly mixed into sterile centrifuge tube, and 2 μ g Plasmid DNA of addition are uniformly mixed, and temperature control is 37 DEG C.The present invention has the characteristics that at low cost, simple for production, quickly and efficiently.

Description

A kind of safe and efficient CRISPR/Cas9 gene editing method
Technical field
The present invention relates to gene engineering technology field more particularly to a kind of safe and efficient CRISPR/Cas9 gene editings Method.
Background technique
CRISPR-Cas9 is a kind of adaptive immunity defence that bacterium and archeobacteria are formed during long-term evolution, can For fighting the virus and exogenous DNA of invasion.And CRISPR-Cas9 gene editing technology, then it is specific to target gene progress The technology of DNA modification, this technology are also the method currently used for forward position in gene editing.With the base on the basis CRISPR-Cas9 Because editing technique all shows great application prospect in the application field that series of genes is treated, for example, blood disease, tumour and Other genetic diseases, so a kind of it is proposed that safe and efficient CRISPR/Cas9 gene editing method.
Summary of the invention
The purpose of the present invention is to solve disadvantages existing in the prior art, and the one kind proposed is safe and efficient CRISPR/Cas9 gene editing method.
To achieve the goals above, present invention employs following technical solutions:
Design a kind of safe and efficient CRISPR/Cas9 gene editing method, comprising the following steps:
S1, the target-gene sequence on target gene is determined, and opens the DNA double spiral of target gene, used To it into shearing, the DNA sequence dna of target gene causes to be broken Cas9 vitro enzyme, and knockout goes genetic fragment in spite of illness;
S2, design sgRNA sequence, and carry out artificial synthesized, be then combined sgRNA and Cas9, and to DNA into Row is repaired, incubation at room temperature 10min;
S3, the bacterium for choosing competence, thaw to it, take the DNA repaired in S2 that 10 μ l are added, are added to 50 In the competent cell of μ l, it is uniformly mixed, is put into and stands 30min on ice;
S4, strain is inoculated into BL solution, keeping temperature is 37 DEG C, it is cultivated in the environment that revolving speed is 250r/min, and It is stayed overnight;
S5, picking monoclonal, using alkaline lysis method of extracting plasmid, and are detected;
6 μ l transfection reagent PEI are added into sterile centrifuge tube in the DMEM culture medium of S6, absorption serum-free and antibiotic And blow and beat and be uniformly mixed, room temperature 10min, and 2 μ g Plasmid DNA are added and are uniformly mixed, it is placed at room temperature for 15min, then by mixed liquor Cell culture is added to be uniformly mixed, temperature control is 37 DEG C, and culture solution is added and is mixed.
Preferably, the culture solution 4-6h in cell culture is replaced, and culture medium is given birth to by balance salt water, amino acid, dimension Element, carbohydrate, inorganic ions, calf serum composition.
Preferably, when extracting plasmid to alkaline lysis, comprising the following steps:
A, choose the bacterium solution in S4, be placed in centrifuge tube, be then added sodium hydroxide solution, and to centrifuge tube it is upper and lower into Row is reverse;
B, acetic acid first solution is then added, turn upside down shaking 8s, is subsequently placed in 3-5min on ice, is then added Detergent SDS carries out centrifugal treating to it with centrifuge, and chromosomal DNA has from solution with denatured protein and cell fragment Precipitate to effect;
C, supernatant is then taken out, is then added isopropanol in supernatant, Plasmid DNA can generate precipitating, then by plasmid DNA takes out.
Preferably, the bacterium of the competence of selection is Escherichia coli.
Preferably, sgRNA length is less than 80bp.
Preferably, the bacterium of competence produce the following steps are included:
1), by cell be added fluid nutrient medium in, in 37 DEG C of culture 1h, transfer it on 37 DEG C of shaking tables with 200r/min speed culture 2-3h is centrifuged 2min at 4 DEG C with the speed of 8000r/min;
2) it, then prepared by CaCl2 solution, and sterilized to CaCl2 solution at 200-300 DEG C of temperature, then Natural cooling is carried out to place it in 4-6min on ice after the completion of cooling and be eventually adding CaCl2 solution, and be kept on ice 30min obtains competent cell.
A kind of safe and efficient CRISPR/Cas9 gene editing method proposed by the present invention, beneficial effect are: have at This is low, simple for production, quickly and efficiently the characteristics of, while sgRNA is designed, increases the stability of sgRNA, reduce simultaneously The possibility that sgRNA misses the target.
Specific embodiment
Below in conjunction with the embodiment of the present invention, technical solution in the embodiment of the present invention is clearly and completely retouched It states, it is clear that described embodiments are only a part of the embodiments of the present invention, instead of all the embodiments.
Embodiment 1
A kind of safe and efficient CRISPR/Cas9 gene editing method, comprising the following steps:
S1, the target-gene sequence on target gene is determined, and opens the DNA double spiral of target gene, used To it into shearing, the DNA sequence dna of target gene causes to be broken Cas9 vitro enzyme, and knockout goes genetic fragment in spite of illness;
S2, design sgRNA sequence, and carry out artificial synthesized, be then combined sgRNA and Cas9, and to DNA into Row is repaired, and incubation at room temperature 10min, sgRNA length is less than 80bp, increases the stability of sgRNA, while reducing sgRNA and missing the target Possibility;
The bacterium of S3, the bacterium for choosing competence, the competence of selection are Escherichia coli, thaw, are taken in S2 to it The DNA that repairs 10 μ l are added, be added in the competent cell of 50 μ l, be uniformly mixed, be put into and stand 30min on ice;
S4, strain is inoculated into BL solution, keeping temperature is 37 DEG C, it is cultivated in the environment that revolving speed is 250r/min, and It is stayed overnight;
S5, picking monoclonal, using alkaline lysis method of extracting plasmid, and are detected;
6 μ l transfection reagent PEI are added into sterile centrifuge tube in the DMEM culture medium of S6, absorption serum-free and antibiotic And blow and beat and be uniformly mixed, room temperature 10min, and 2 μ g Plasmid DNA are added and are uniformly mixed, it is placed at room temperature for 15min, then by mixed liquor Cell culture is added to be uniformly mixed, temperature control is 37 DEG C, and culture solution is added and is mixed, the culture in cell culture Liquid 4h is replaced, and culture medium is made of balance salt water, amino acid, vitamin, carbohydrate, inorganic ions, calf serum, Germiparity proliferation is promoted, ensure that the living environment of culture cell growth and breeding.
When extracting plasmid to alkaline lysis, comprising the following steps:
A, choose the bacterium solution in S4, be placed in centrifuge tube, be then added sodium hydroxide solution, and to centrifuge tube it is upper and lower into Row is reverse;
B, acetic acid first solution is then added, turn upside down shaking 8s, is subsequently placed in 3-5min on ice, is then added Detergent SDS carries out centrifugal treating to it with centrifuge, and chromosomal DNA has from solution with denatured protein and cell fragment Precipitate to effect;
C, supernatant is then taken out, is then added isopropanol in supernatant, Plasmid DNA can generate precipitating, then by plasmid DNA takes out.
The bacterium of competence produce the following steps are included:
1), by cell be added fluid nutrient medium in, in 37 DEG C of culture 1h, transfer it on 37 DEG C of shaking tables with 200r/min speed culture 2h is centrifuged 2min at 4 DEG C with the speed of 8000r/min;
2) it, then prepared by CaCl2 solution, and sterilized to CaCl2 solution at 200 DEG C of temperature, then carried out Natural cooling places it in 4-6min on ice and is eventually adding CaCl2 solution, and be kept on ice 30min, obtain after the completion of cooling Obtain competent cell.
Embodiment 2
A kind of safe and efficient CRISPR/Cas9 gene editing method, comprising the following steps:
S1, the target-gene sequence on target gene is determined, and opens the DNA double spiral of target gene, used To it into shearing, the DNA sequence dna of target gene causes to be broken Cas9 vitro enzyme, and knockout goes genetic fragment in spite of illness;
S2, design sgRNA sequence, and carry out artificial synthesized, be then combined sgRNA and Cas9, and to DNA into Row is repaired, and incubation at room temperature 10min, sgRNA length is less than 80bp, increases the stability of sgRNA, while reducing sgRNA and missing the target Possibility;
The bacterium of S3, the bacterium for choosing competence, the competence of selection are Escherichia coli, thaw, are taken in S2 to it The DNA that repairs 10 μ l are added, be added in the competent cell of 50 μ l, be uniformly mixed, be put into and stand 30min on ice;
S4, strain is inoculated into BL solution, keeping temperature is 37 DEG C, it is cultivated in the environment that revolving speed is 250r/min, and It is stayed overnight;
S5, picking monoclonal, using alkaline lysis method of extracting plasmid, and are detected;
6 μ l transfection reagent PEI are added into sterile centrifuge tube in the DMEM culture medium of S6, absorption serum-free and antibiotic And blow and beat and be uniformly mixed, room temperature 10min, and 2 μ g Plasmid DNA are added and are uniformly mixed, it is placed at room temperature for 15min, then by mixed liquor Cell culture is added to be uniformly mixed, temperature control is 37 DEG C, and culture solution is added and is mixed, the culture in cell culture Liquid 6h is replaced, and culture medium is made of balance salt water, amino acid, vitamin, carbohydrate, inorganic ions, calf serum, Germiparity proliferation is promoted, ensure that the living environment of culture cell growth and breeding.
When extracting plasmid to alkaline lysis, comprising the following steps:
A, choose the bacterium solution in S4, be placed in centrifuge tube, be then added sodium hydroxide solution, and to centrifuge tube it is upper and lower into Row is reverse;
B, acetic acid first solution is then added, turn upside down shaking 8s, is subsequently placed in 3-5min on ice, is then added Detergent SDS carries out centrifugal treating to it with centrifuge, and chromosomal DNA has from solution with denatured protein and cell fragment Precipitate to effect;
C, supernatant is then taken out, is then added isopropanol in supernatant, Plasmid DNA can generate precipitating, then by plasmid DNA takes out.
The bacterium of competence produce the following steps are included:
1), by cell be added fluid nutrient medium in, in 37 DEG C of culture 1h, transfer it on 37 DEG C of shaking tables with 200r/min speed culture 3h is centrifuged 2min at 4 DEG C with the speed of 8000r/min;
2) it, then prepared by CaCl2 solution, and sterilized to CaCl2 solution at 300 DEG C of temperature, then carried out Natural cooling places it in 4-6min on ice and is eventually adding CaCl2 solution, and be kept on ice 30min, obtain after the completion of cooling Obtain competent cell.
The foregoing is only a preferred embodiment of the present invention, but scope of protection of the present invention is not limited thereto, Anyone skilled in the art in the technical scope disclosed by the present invention, according to the technique and scheme of the present invention and its Inventive concept is subject to equivalent substitution or change, should be covered by the protection scope of the present invention.

Claims (6)

1. a kind of safe and efficient CRISPR/Cas9 gene editing method, which comprises the following steps:
S1, the target-gene sequence on target gene is determined, and opens the DNA double spiral of target gene, using Cas9 body To it into shearing, the DNA sequence dna of target gene causes to be broken exoenzyme, and knockout goes genetic fragment in spite of illness;
S2, sgRNA sequence is designed, and carries out artificial synthesized, be then combined sgRNA and Cas9, and DNA is repaired It is multiple, incubation at room temperature 10min;
S3, the bacterium for choosing competence, thaw to it, take the DNA repaired in S2 that 10 μ l are added, are added to 50 μ l's In competent cell, it is uniformly mixed, is put into and stands 30min on ice;
S4, strain is inoculated into BL solution, keeping temperature is 37 DEG C, is cultivated in the environment that revolving speed is 250r/min, and carry out Overnight;
S5, picking monoclonal, using alkaline lysis method of extracting plasmid, and are detected;
The DMEM culture medium of S6, absorption serum-free and antibiotic are added 6 μ l transfection reagent PEI and simultaneously blow into sterile centrifuge tube It beats and is uniformly mixed, room temperature 10min, and 2 μ g Plasmid DNA are added and are uniformly mixed, it is placed at room temperature for 15min, then mixed liquor is added Cell culture is uniformly mixed, and temperature control is 37 DEG C, and culture solution is added and is mixed.
2. a kind of safe and efficient CRISPR/Cas9 gene editing method according to claim 1, which is characterized in that thin Culture solution 4-6h in born of the same parents' culture plate is replaced, and culture medium is by balance salt water, amino acid, vitamin, carbohydrate, inorganic Ion, calf serum composition.
3. a kind of safe and efficient CRISPR/Cas9 gene editing method according to claim 1, which is characterized in that When extracting plasmid to alkaline lysis, comprising the following steps:
A, the bacterium solution in S4 is chosen, is placed in centrifuge tube, sodium hydroxide solution, and running up and down to centrifuge tube is then added ?;
B, acetic acid first solution is then added, turn upside down shaking 8s, is subsequently placed in 3-5min on ice, be then added in de-sludging Agent SDS carries out centrifugal treating to it with centrifuge, chromosomal DNA and denatured protein and cell fragment from solution effectively It precipitates;
C, supernatant is then taken out, isopropanol is then added in supernatant, Plasmid DNA can generate precipitating, then Plasmid DNA is taken Out.
4. a kind of safe and efficient CRISPR/Cas9 gene editing method according to claim 1, which is characterized in that choosing The bacterium of the competence taken is Escherichia coli.
5. a kind of safe and efficient CRISPR/Cas9 gene editing method according to claim 1, which is characterized in that SgRNA length is less than 80bp.
6. a kind of safe and efficient CRISPR/Cas9 gene editing method according to claim 1, which is characterized in that sense Produced by the bacterium of state the following steps are included:
1), cell is added in fluid nutrient medium, in 37 DEG C of culture 1h, is transferred it on 37 DEG C of shaking tables with 200r/min Speed culture 2-3h is centrifuged 2min at 4 DEG C with the speed of 8000r/min;
2) it, then prepared by CaCl2 solution, and sterilized to CaCl2 solution at 200-300 DEG C of temperature, then carried out Natural cooling places it in 4-6min on ice and is eventually adding CaCl2 solution, and be kept on ice 30min, obtain after the completion of cooling Obtain competent cell.
CN201910536641.1A 2019-06-20 2019-06-20 A kind of safe and efficient CRISPR/Cas9 gene editing method Pending CN110272921A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910536641.1A CN110272921A (en) 2019-06-20 2019-06-20 A kind of safe and efficient CRISPR/Cas9 gene editing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910536641.1A CN110272921A (en) 2019-06-20 2019-06-20 A kind of safe and efficient CRISPR/Cas9 gene editing method

Publications (1)

Publication Number Publication Date
CN110272921A true CN110272921A (en) 2019-09-24

Family

ID=67961292

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910536641.1A Pending CN110272921A (en) 2019-06-20 2019-06-20 A kind of safe and efficient CRISPR/Cas9 gene editing method

Country Status (1)

Country Link
CN (1) CN110272921A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106566838A (en) * 2016-11-14 2017-04-19 上海伯豪生物技术有限公司 MiR-126 full-length gene knockout kit based on CRISPR-Cas9 technology and application thereof
CN107406875A (en) * 2014-12-20 2017-11-28 阿克生物公司 Use the composition and method of CRISPR/Cas systematic proteins targeting abatement, enrichment and segmentation nucleic acid
CN108486111A (en) * 2018-04-04 2018-09-04 山西医科大学 The method and its specificity sgRNA of CRISPR-Cas9 targeting knock out people's SMYD3 genes
WO2019005851A1 (en) * 2017-06-26 2019-01-03 Arizona Board Of Regents On Behalf Of Arizona State University A universal platform to enhance crispr-based gene editing for in vivo therapies

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107406875A (en) * 2014-12-20 2017-11-28 阿克生物公司 Use the composition and method of CRISPR/Cas systematic proteins targeting abatement, enrichment and segmentation nucleic acid
CN106566838A (en) * 2016-11-14 2017-04-19 上海伯豪生物技术有限公司 MiR-126 full-length gene knockout kit based on CRISPR-Cas9 technology and application thereof
WO2019005851A1 (en) * 2017-06-26 2019-01-03 Arizona Board Of Regents On Behalf Of Arizona State University A universal platform to enhance crispr-based gene editing for in vivo therapies
CN108486111A (en) * 2018-04-04 2018-09-04 山西医科大学 The method and its specificity sgRNA of CRISPR-Cas9 targeting knock out people's SMYD3 genes

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PHILIP J.R. ROCHE等: "Double-Stranded Biotinylated Donor Enhances Homology-Directed Repair in Combination with Cas9 Monoavidin in Mammalian Cells", 《THE CRISPR JOURNAL》 *
刘志强: "《电子科技大学出版社》", 31 July 2017, 中国轻工业出版社 *
李进等: "《现代发酵工程实验指导》", 31 May 2017, 电子科技大学出版社 *

Similar Documents

Publication Publication Date Title
JP2022115994A5 (en)
US9657298B2 (en) Recombinant nitrogen-fixing bacterial strain, inoculum containing the same and application methods
CN107354119A (en) A kind of genetic engineering bacterium of high yield hyaluronic acid and its construction method and application
CN111849979B (en) sgRNA for targeted knockout of RPSA gene and construction method of RPSA gene knockout cell line
BR112020004575A2 (en) polynucleotide, vector, microorganism of the genus corynebacterium, methods for producing target substance and for preparing a fermented composition, and fermented composition.
CN102181389B (en) Method for breeding Bacillaceae with high spore yield
CN107267468A (en) A kind of method of serum free suspension culture Pseudorabies virus
CN106520802A (en) GAD gene for increasing stress tolerance of lactic acid bacteria and application thereof
CN104830748A (en) Method for weakening hemB gene expression to increase yield of 5-aminolevulinic acid synthesized by escherichia coli
CN105543281A (en) Chlamydomonas reinhardtii efficient library building method using square wave electroporation
CN107881140A (en) The Leuconostoc mesenteroides mutant strain of one plant height production mannitol and its application process
CN110272921A (en) A kind of safe and efficient CRISPR/Cas9 gene editing method
CN105441373B (en) One plant of streptomyces albulus genetic engineering bacterium and its construction method and application
CN109628493B (en) Gene editing system for preparing T cells capable of being transplanted by variant
CN104789478B (en) A kind of cultural method and culture systems of haematococcus pluvialis algae kind
CN106857252B (en) Disinfection by chlorine dioxide culture medium is quickly bred for potato seedling or the method for Stem covered by vermiculite
CN102234624B (en) Genetic engineering strain for expression and generation of bacillus subtilis arginase, and constructing method thereof
CN103233035B (en) China tachyplesin constitutive yeast expression vector and preparation method thereof
CN106834180B (en) Improve enterobacteria 3bh19 and its application of Phyllosphere of cucumber Tiny ecosystem prevention and treatment downy mildew
CN106119276B (en) Method for establishing agrobacterium-mediated erigeron breviscapus efficient transfection system
CN110272915B (en) Method for cultivating bacterial leaf blight resistant rice by gene editing technology
CN113832129A (en) Chitosanase mutant CsnBa1 and application thereof
CN104911155B (en) Using the heat-resistant of genetic engineering transformation against SOD and its encoding gene and application
CN108739402A (en) A method of improving corn hybrid seed production efficiency
CN114806986B (en) Genetically engineered bacterium for high-yield rocmycin as well as construction method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190924

RJ01 Rejection of invention patent application after publication